Clear cell renal cell carcinoma

It starts in cells lining small kidney tubules. The care plan depends on where the tumour is, its size and spread, kidney function, other health conditions and tumour biology. Options can include surgery, ablation, immunotherapy or targeted therapy.

Clear cell refers to pale-looking tumour cells seen by a pathologist. Scans define the kidney mass and look for involvement of nearby structures, lymph nodes or distant organs. Blood and urine tests help assess kidney function, anaemia and general readiness for treatment.

A biopsy may be used when its result would change management, although some kidney tumours are diagnosed after removal. Stage describes disease extent; grade describes how abnormal and active the cells appear. They are related pieces of information, not interchangeable labels.

For disease confined to the kidney, surgery may remove only the tumour-bearing part or the whole kidney, depending on location, complexity and remaining kidney function. Ablation may destroy a selected tumour without removing it and is considered when the tumour and a person's health make that approach suitable.

When cancer has spread or carries a higher risk of returning, systemic treatment may use medicines that activate immune responses, target growth pathways, or combine approaches. The sequence is tailored to previous care, tumour behaviour, side effects and treatment goals.

Protecting kidney health remains part of follow-up. Review prescription and non-prescription medicines with the team, keep blood pressure and kidney tests monitored as advised, and report treatment side effects early rather than stopping cancer medicine on your own.

Get urgent medical assessment for heavy blood in the urine or clots with difficulty passing urine, sudden severe side or abdominal pain, fainting, chest pain, marked breathlessness, a seizure, or new one-sided weakness. These problems require assessment even though they can arise from causes other than kidney cancer.

During treatment, contact the oncology team promptly for fever, much less urine, persistent diarrhoea or vomiting, severe rash, yellowing of the eyes, worsening cough, unusual bleeding or profound fatigue. Immunotherapy and targeted therapy can affect organs beyond the kidney, and early review can prevent complications from becoming harder to manage.

Ask whether pathology has confirmed clear cell carcinoma, what stage and grade mean for you, and how each option may affect kidney function. Clarify whether surgery would spare part of the kidney, why ablation is or is not suitable, and which symptoms should trigger a same-day call during systemic treatment.